Skip to content

Interscalene Block Versus Costoclavicular Block for Shoulder Surgery

A Randomized Comparison Between Interscalene and Costoclavicular Infraclavicular Brachial Plexus Blocks For Arthroscopic Shoulder Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03411343
Enrollment
44
Registered
2018-01-26
Start date
2018-04-09
Completion date
2018-07-06
Last updated
2018-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diaphragmatic Paralysis, Pain, Postoperative, Shoulder Pain, Surgical Procedure, Unspecified

Keywords

Postoperative Shoulder Analgesia, Hemidiaphragmatic Paralysis, Alternative blocks

Brief summary

Interscalene brachial plexus block constitutes the analgesic criterion standard for shoulder surgery. However, it is associated with a high incidence of hemidiaphragmatic paralysis (HDP) that may not be tolerated by patients with chronic pulmonary disease. This randomized controlled trial (RCT) will compare ultrasound-guided interscalene block (ISB) and costoclavicular infraclavicular block (CCICB) in patients undergoing arthroscopic shoulder surgery. The main outcome is static pain at 30 minutes after arrival in the post anesthesia care unit (PACU) as measured by a numerical rate scale (NRS) from 0 to 10. Our research hypothesis is that interscalene and costoclavicular infraclavicular blocks will result in equivalent postoperative analgesia at 30 minutes in the PACU. The equivalence margin is set at 2 points.

Interventions

PROCEDUREInterscalene Block

Injection with ultrasound guidance of 20mL of levobupivacaine 0.5% with 5 micrograms of epinephrine per mL in the interscalene groove of the brachial plexus.

Ultrasound guided brachial plexus block injecting 20mL of 0.5% levobupivacaine with 5 micrograms of epinephrine per mL in between the cords of the brachial plexus at the costoclavicular infraclavicular space.

Sponsors

University of Chile
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing arthroscopic shoulder surgery * American Society of Anesthesiologists classification 1-3 * Body mass index between 20 and 35

Exclusion criteria

* Adults who are unable to give their own consent * Pre-existing neuropathy * Coagulopathy * Obstructive or restrictive pulmonary disease * Renal failure * Hepatic failure * Allergy to local anesthetics * Pregnancy * Prior surgery in the corresponding side of the neck or infraclavicular fossa * Chronic pain syndromes requiring opioid intake at home

Design outcomes

Primary

MeasureTime frameDescription
Static pain at 30 minutes after arrival in the PACU30 minutesEvaluated with a NRS from 0 to 10

Secondary

MeasureTime frameDescription
Postoperative static pain at 2 hours2 hoursEvaluated with a NRS from 0 to 10
Postoperative static pain at 3 hours3 hoursEvaluated with a NRS from 0 to 10
Postoperative static pain at 6 hours6 hoursEvaluated with a NRS from 0 to 10
Postoperative static pain at 12 hours12 hoursEvaluated with a NRS from 0 to 10
Postoperative static pain at 24 hours24 hoursEvaluated with a NRS from 0 to 10
Incidence of HDP at 30 minutes after interscalene or costoclavicular infraclavicular block30 minutes post injectionUltrasound diagnosed HDP
Incidence of HDP at 30 minutes after arrival to PACU30 minutes after arrival to the PACUUltrasound diagnosed HDP
Block performance time1 hour before surgeryTime from skin disinfection until the end of local anesthetic injection
Static pain at 60 minutes after arrival in the PACU60 minutesEvaluated with a NRS from 0 to 10
Incidence of complete block30 minutes post injectionPercentage of blocks with a minimal sensorimotor composite score of 6 points out of a maximum of 8 points at 30 minutes post injection
Procedural pain during blocks1 hour before surgeryEvaluated with a NRS from 0 to 10
Onset time1 hour before surgeryTime required to reach a minimal sensorimotor composite score of 6 points out of a maximum of 8 points
Intraoperative opioid requirementsIntraoperative periodTotal amount of fentanyl required during general anesthesia
Surgical durationIntraoperative periodTime between skin incision and closure
Postoperative opioid consumption24 hours after surgeryTotal amount of morphine required during the first 24 hours after surgery
Patient satisfaction24 hours after surgeryPatient satisfaction measured using a NRS 0 to 10 (0 = unsatisfied; 10 =very satisfied)
Block- and opioid-related side effects1 weekIncidence of side effects
Sensory and Motor block score30 minutes post injectionSensorimotor block assessed every 5 minutes until 30 minutes using a 8-point composite score

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026